Mercia Asset Management is an AIM-quoted group with c.£1.4bn of assets under management, operating through private equity, debt and venture capital portfolios.
Mercia Asset Management and Pearson backed the Series A round to fund international expansion and team growth.
"Daniela Tsoneva, Investor at Mercia, said: “We are excited to support Nelson and his team in their quest to transform workplace learning. HowNow’s dynamic matching technology ensures users receive the right learning content at the right time. The company is a pioneer in the relatively new but fast-growing learning experience sector and has the potential to become a market leader. The funding will help it expand its global footprint and continue its rapid growth trajectory."
The funding round was backed by a group of existing investors alongside a grant from the European Innovation Council.
"This is a very significant funding milestone in our mission to detect cancer early and improve survival and quality of life for patients. Having demonstrated our multi-cancer capability, we can now focus on building the pipeline of organ-specific tests, beginning with a multi-center study to gain regulatory approval for the brain cancer test. We will also expand our data on colorectal cancer, one of the leading causes of death worldwide, and continue our work on collaborative projects."
The biomedical startup has closed a £2.3m Series A round backed by Mercia Asset Management, ACF Investors, Wren Capital and Wealth Club.
"Adapttech brought its first product to market during 2021, successfully securing a number of sales. We are delighted to be supporting the team with a follow-on investment to continue to scale the business and build out the product portfolio."
The oversubscribed funding round includes participation from Mercia Asset Management, Calculus Capital, Downing Ventures, and BGF.
"We are delighted that our investors have emphatically and unanimously backed our vision to become leaders in next generation affinity reagents following the achievement of the key milestones we set together 18 months ago. We will continue to bring highly talented and experienced people to the business at all levels to accelerate our growth. This will be delivered by completing the industrialisation of our technology in targeted applications and bringing exciting new products to market to address unmet needs with high performance customer-centric solutions, which in turn will drive market adoption."
The investment from Mercia will fund cloud software development and international expansion.
"The impact of our Cell Site Analysis Suite (CSAS) was demonstrated most recently through the results CSAS delivered for the Metropolitan Police Service to disrupt county lines."
Koch Disruptive Technologies led the Series B round to support the commercialisation of the Veros diagnostics platform.
"This Series B round is crucial in providing us with the resources to grow our Veros platform to revolutionize decentralized point-of-care testing; and it is particularly important as we commercialize our Veros COVID-19 test, which delivers laboratory quality results directly to users within minutes, without an instrument. This will be an essential tool in the effective management of outbreaks of this and other diseases,"
The Birmingham-based tele-optometry manufacturer has raised £2.5m from investors including Midven, Mercia Asset Management and the Future Fund.
"We at Eyoto have all the ingredients to become a major force within the embryonic field of tele-optometry: a great team, a range of game-changing technologies and, as this funding round proves, supportive investors."
Downing Ventures, BGF, Mercia, and Calculus Capital backed the Bedfordshire nanotechnology business in its latest round.
"We are delighted to be bringing such high-profile investors on board, who share our ambitious growth plans for the business. This significant investment is a strong endorsement of the MIPs technology, it will enable us to scale our operations and take the business to the next level. MIPs offer many advantages and provide solutions to enable new applications that push the limit of what was previously possible. This investment will enable us to rapidly expand our operations to service these opportunities and bring exciting new products to the market."
